CA
Corriente Advisors Portfolio holdings
AUM
$3.45M
This Quarter Return
+82.51%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$154M
AUM Growth
+$154M
(+67%)
Cap. Flow
+$35.1M
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
95.94%
Holding
21
New
10
Increased
1
Reduced
4
Closed
5
Top Buys
| 1 |
Sonos
SONO
|
$23M |
| 2 |
Replimune Group
REPL
|
$12.1M |
| 3 |
uniQure
QURE
|
$8.11M |
| 4 |
Ocular Therapeutix
OCUL
|
$6M |
| 5 |
Celldex Therapeutics
CLDX
|
$5.98M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$6.63M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$4.69M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
$4.2M |
| 4 |
Cue Biopharma
CUE
|
$3.92M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$3.57M |
Sector Composition
| 1 | Healthcare | 49.35% |
| 2 | Technology | 36.99% |
| 3 | Consumer Discretionary | 1.4% |
| 4 | Materials | 0.59% |
| 5 | Real Estate | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $34.1M | 22.11% | 1,900,000 +210,900 | +12% | +$3.79M |
|
|
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $23M | 14.91% | 147,500 -42,500 | -22% | -$6.63M |
|
|
3
Sonos
SONO
$1.68B
| $23M | 14.88% | +1,570,000 | New | +$23M |
|
|
APTO
4
DELISTED
Aptose Biosciences, Inc.
APTO
| $17.5M | 11.33% | 2,771,312 -146,688 | -5% | -$926K |
|
|
5
Cue Biopharma
CUE
$60M
| $16.2M | 10.48% | 659,987 -160,013 | -20% | -$3.92M |
|
|
6
Replimune Group
REPL
$422M
| $12.1M | 7.81% | +485,000 | New | +$12.1M |
|
|
7
uniQure
QURE
$896M
| $8.11M | 5.26% | +180,000 | New | +$8.11M |
|
|
8
Ocular Therapeutix
OCUL
$2.12B
| $6M | 3.89% | +720,000 | New | +$6M |
|
|
9
Celldex Therapeutics
CLDX
$1.47B
| $5.98M | 3.87% | +460,000 | New | +$5.98M |
|
10
Tesla
TSLA
$1.08T
| $2.16M | 1.4% | 2,000 | – | – |
|
11
Arrowhead Research
ARWR
$3.05B
| $1.73M | 1.12% | +40,000 | New | +$1.73M |
|
12
DiaMedica Therapeutics
DMAC
$295M
| $1.4M | 0.9% | +201,248 | New | +$1.4M |
|
13
Pan American Silver
PAAS
$12.3B
| $912K | 0.59% | +30,000 | New | +$912K |
|
14
Cardiff Oncology
CRDF
$140M
| $869K | 0.56% | +173,361 | New | +$869K |
|
|
PVLA
15
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $837K | 0.54% | 270,000 -1,511,921 | -85% | -$4.69M |
|
|
RWT
16
Redwood Trust
RWT
$791M
| $525K | 0.34% | +75,000 | New | +$525K |
|
|
17
Grayscale Bitcoin Trust
GBTC
$43.4B
| – | – | -590,000 | Closed | -$4.2M |
|
18
Schrodinger
SDGR
$1.44B
| – | – | -60,000 | Closed | -$2.59M |
|
|
VIRX
19
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – | -3,021,692 | Closed | -$1.25M |
|
|
BLU
20
DELISTED
BELLUS Health Inc.
BLU
| – | – | -148,666 | Closed | -$1.48M |
|
|
EPZM
21
DELISTED
Epizyme, Inc
EPZM
| – | – | -230,000 | Closed | -$3.57M |
|